Marine natural compounds could be potential treatments for triple negative breast cancer
The oceans cover more than 70 percent of the earth's surface and provide a rich source of unique, bioactive natural products. Their chemical diversity and structural complexity represent an untapped supply of potential new...
Healthcare And Biotechnology Dashboard – Update – Seeking Alpha
Executive summary
This article series provides a monthly dashboard of industries in each sector of the GICS classification. It compares valuation and quality factors relative to their historical averages.
Biotechnology looks significantly underpriced relative to historical...
Hedging success – European Biotechnology
Although the Swiss biotech sector continues to grow and the annual Swiss Biotech Day is as sought-after as never before, panelists and attendees remain cautious with their predictions. A reoccurring theme at the event...
Genentech, Parvus Therapeutics Launch Up-to-$800M Autoimmune Collaboration
Genentech, a Member of the Roche Group, today launched an up-to-$800 million partnership with Parvus Therapeutics to develop, manufacture, and commercialize new treatments for inflammatory bowel disease (IBD), autoimmune liver diseases (ALD), and celiac...
Brain network activity can improve in epilepsy patients after surgery
Credit: Vanderbilt University Medical Center
Successful epilepsy surgery can improve brain connectivity similar to patterns seen in people without epilepsy, according to a new study published in...
Scientists unravel how intelligent neural network predicts the functions of proteins
Intelligent virtual companions like Alexa, Siri, and Google Assistant have long become integrated into our everyday lives. And intelligent computational programs, so-called algorithms, have also evolved as an integral tool in scientific research.
The huge...
BioTechnology Stocks | There’s A Good Reason Investors Love These Shares – MicroSmallCap
Biotechnology stocks offer investors the potential to profit from the next generation of treatments. And because treatments are vast—covering everything from serious illness to cosmetic enhancements, investors are afforded a lot of choices.
Because of...
Prostate Cancer Target Blockade Tackles Elusive Onocogene
Targeting a protein that is essential for supporting the MYC oncogene could offer a new therapeutic approach to preventing prostate cancer (PC) metastasis, according to early research results in laboratory-grown cells and mouse models....
Exploring the possibility of a broadly effective dengue vaccine
Dengue is on the rise, with about 20,000 patients dying each year from this mosquito-borne disease, yet despite ongoing efforts a broadly effective dengue vaccine is not available. The complex challenges, current status of...
PDS Biotechnology Reports First Quarter 2019 Financial Results and Provides Business Update – Yahoo...
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)--sm Mt(0.8em)--sm" type="text" content="BERKELEY HEIGHTS, N.J., May 14, 2019 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (“PDS Biotechnology”) (PDSB), a clinical-stage immuno-oncology company pioneering the development of novel multifunctional immunotherapeutic products,...














